. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Amir Atapour
Advertisement
Amir Atapour is a PhD student at Department of Medical Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Iran.
Articles by Amir Atapour
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
2
Regeneron's Libtayo Earns CHMP Nod for Expanded EU Dosing
3
Lilly’s Omvoh Reaches 50% One-Year Remission in Pediatric Ulcerative Colitis
4
The BioPharm Brief: New Approval, Pediatric Progress, and Durable Remission
5